Policies and Practices of Open Science in Medical Journals
Overview
This study evaluates the implementation of open science practices in leading medical journals, focusing on policies and article-level transparency.
Background
Open science practices, such as study registration and data sharing, are critical for enhancing the quality and reproducibility of biomedical research. The International Committee of Medical Journal Editors (ICMJE) has mandated clinical trial registration since 2005, yet adherence to data-sharing requirements remains limited.
Data Highlights
This study utilized a cross-sectional design to assess open science practices across 10 leading medical journals, focusing on compliance with the 2025 Transparency and Openness Promotion (TOP) Guidelines.
Key Findings
Prospective clinical-trial registration became a requirement under ICMJE in 2005.
Data-sharing statements for clinical trials were mandated by ICMJE in 2018, but adherence is still low.
BMJ and PLOS Medicine have implemented stringent data-sharing requirements for clinical trials.
Open science practices have been primarily focused on clinical trials, with observational research lagging behind.
Automated tools for monitoring open science practices are being developed to enhance evaluation methods.
Evaluation of journals' open science policies is necessary to ensure transparency and credibility in biomedical research.
Clinical Implications
The findings underscore the need for journals to enhance their open science policies and practices to improve research transparency. Clinicians and researchers should advocate for adherence to established guidelines to foster a more reproducible research environment.
Conclusion
This study highlights significant gaps in the implementation of open science practices among medical journals, emphasizing the need for ongoing evaluation and improvement.
Investigators compared intra-articular microbial profiles and predicted metabolic pathways in patients with hip osteoarthritis and nonarthritic controls.
